Fig. 1From: Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort studyFlowchart of study cohort selection in the US and Japanese cohorts. Childhood 6 to < 13 years of age; adolescence: 13 to < 18 years of ageBack to article page